Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion after Rituximab Therapy: Case Report

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

ObjectivesPersistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion years after rituximab therapy.MethodsThis is a case report from a German academic hospital. In addition to repeated clinical examinations, repeated brain MRI and extended CSF and laboratory diagnostics were performed. We used the CARE checklist when writing our report.ResultsA 38-year-old man presented with high fever (>40°C), severe headache, and progressive neurologic and cognitive deficits. As result of previous lymphoma therapy with rituximab years ago, prolonged B-cell aplasia was detected. To restore humoral immunity, the patient received repeated infusions of immunoglobulins. In the end, a complete restitution of the physical and mental condition was achieved with the established therapy.DiscussionThis case report should emphasize the importance of assessing humoral immunity even years after B-cell depletion therapy, especially in case of opportunistic infections.

Cite

CITATION STYLE

APA

Jacksch, C., Dargvainiene, J., Böttcher, S., Diedrich, S., Leypoldt, F., Stürner, K., … Schäffer, E. (2023). Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion after Rituximab Therapy: Case Report. Neurology: Neuroimmunology and NeuroInflammation, 10(6). https://doi.org/10.1212/NXI.0000000000200171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free